Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy

Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone... Graefes Arch Clin Exp Ophthalmol (2017) 255:1565–1571 DOI 10.1007/s00417-017-3700-3 RETINAL DISORDERS Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy 1,2 1 1 1 Tsutomu Sakai & Noriko Kato & Masaomi Kubota & Hiroshi Tsuneoka Received: 20 September 2016 /Revised: 14 May 2017 /Accepted: 30 May 2017 /Published online: 11 June 2017 Springer-Verlag Berlin Heidelberg 2017 . . Abstract Keywords Aflibercept Photodynamic therapy Purpose To evaluate the outcome of triple therapy of Triamcinolone acetonide Polypoidal choroidal vasculopathy photodynamic therapy combined with injections of intra- vitreal aflibercept (IVA) and subtenon triamcinolone acetonide for polypoidal choroidal vasculopathy (PCV) Introduction resistant to IVA. Methods A retrospective chart review at a single institu- Polypoidal choroidal vasculopathy (PCV) is a distinct clinical tion was conducted to identify patients with PCV resis- entity that differs from exudative age-related macular degen- tant to treatment with IVA who were switched to treat- eration (AMD) in several ways. PCV is characterized by an ment with triple therapy. In total, 13 eyes from 13 pa- abnormal branching vascular network with polypoidal termi- tients were included in the study. Demographic data, nal bulbs in the inner choroids [1–4]. The pathophysiology of visual acuities, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Graefe's Archive for Clinical and Experimental Ophthalmology Springer Journals

Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy

Loading next page...
 
/lp/springer_journal/effects-of-photodynamic-therapy-plus-intravitreal-aflibercept-with-aOx0iQJ6MP
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Ophthalmology
ISSN
0721-832X
eISSN
1435-702X
D.O.I.
10.1007/s00417-017-3700-3
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial